GeneralConnection.com
➔
Dictionary
Dictionary Search
Go Find!
tarsus
Synonyms
Noun
1. skeletal structure
Usage
The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following First 2026 XDEMVY Sales Outlook - simplywall.st
Tarsus Reports Soaring Xdemvy Sales in Q4, Full Year - Orange County Business Journal
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance - Yahoo Finance
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth - TipRanks
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating - Finviz
Tarsus Pharma COO Neervannan Seshadri sells $641k in stock - Investing.com
What dividend safety score for Tarsus Pharmaceuticals Inc. stock - Dividend Hike & AI Powered Market Trend Analysis - Naître et grandir
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire
Tarsus Pharmaceuticals: Q4 Results Highlight Xdemvy Blockbuster Potential (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - VisionMonday.com
XDEMVY Growth And China Deal Reshape Tarsus Pharmaceuticals Investment Story - simplywall.st
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements - Yahoo Finance
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Has The Market Rerated Tarsus Pharmaceuticals (TARS) Too Cautiously After XDEMVY Adoption Headlines? - Yahoo Finance
A Look At Tarsus Pharmaceuticals (TARS) Valuation After Adding Former Allergan CEO David Pyott To Its Board - Yahoo Finance
Tarsus Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Tarsus Pharmaceuticals at TD Cowen Conference: Eyeing Blockbuster Growth - Investing.com
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - GlobeNewswire
Paul of Tarsus: Cultural Amphibian - The Catholic Thing
A Look At Tarsus Pharmaceuticals (TARS) Valuation After 2025 Results And New Shelf Registration - simplywall.st
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors - GlobeNewswire
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Tarsus Pharma COO Neervannan Seshadri sells $641k in stock By Investing.com - Investing.com Australia
Stream Tarsus Pharma at TD Cowen and Barclays investor events in March - Stock Titan
Does Adding Ophthalmology Veteran David Pyott to the Board Change The Bull Case For Tarsus (TARS)? - Yahoo Finance
What both Paul of Tarsus and Lincoln encourage us to keep in mind regarding romantic love - Williamson Herald
TARSUS PHARMACEUTICALS INC (NASDAQ:TARS) Passes High-Growth Momentum and Minervini Trend Template Screen - ChartMill
Lessons in Category Creation: In Conversation with Bobby Azamian, CEO Tarsus Pharmaceuticals - Endpoints News
Q2 net sales reach $100M for Tarsus’ XDEMVY, with pipeline potential for Lyme rooted in animal health - drugdiscoverytrends.com
Tarsus Pharmaceuticals (TARS) Is Up 14.8% After XDEMVY-Fueled Revenue Surge and New Equity Shelf Filing - simplywall.st
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Tarsus Pharmaceuticals (TARS) Is Up 14.8% After XDEMVY-Fueled Revenue Surge and New Equity Shelf Filing - Sahm
Cherry Bekaert snaps up Washington-based accounting practice Tarsus - International Accounting Bulletin
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative - simplywall.st
Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $105.00 Price Target at Oppenheimer - MarketBeat
Cherry Bekaert acquires Tarsus - Accounting Today
Why Tarsus Pharmaceuticals (TARS) Is Up 21.6% After Xdemvy’s Uptake and New Trial Announcements—And What's Next - Yahoo Finance
A Look At Tarsus Pharmaceuticals (TARS) Valuation After David Pyott Joins The Board - Sahm
Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative - Sahm
Ex-Allergan chief who grew sales to $7B joins Tarsus board - Stock Titan
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Tarsus to Participate in Upcoming Investor Conferences - Bitget
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors - Sahm
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - Sahm
Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last? - Yahoo Finance
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - GlobeNewswire
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Finviz
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire
Cherry Bekaert Bolsters Outsourced Accounting Services With Acquisition of Washington, DC-Based Firm Tarsus - PR Newswire
Tarsus Pharmaceuticals (TARS): Losses Widen Despite Strong Growth Outlook, Challenging Bullish Narratives - Yahoo Finance
St. Paul the Apostle | Patron Saint, Biography, & Facts - Britannica
Tarsus Pharmaceuticals: Making Big Strides (NASDAQ:TARS) - Seeking Alpha
While shareholders of Tarsus Pharmaceuticals (NASDAQ:TARS) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
Tarsus Pharmaceuticals (TARS) Receives Analyst Rating Upgrade fr - GuruFocus
Stocks With Rising Relative Strength: Tarsus Pharmaceuticals - Investor's Business Daily
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD - Investing.com
Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability - Yahoo Finance
Possible Bearish Signals With Tarsus Pharmaceuticals Insiders Disposing Stock - simplywall.st
Tarsus Pharmaceuticals (TARS) Shares Surge Over 11% - GuruFocus
Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals Adds Industry Veteran to Board - TipRanks
Earnings Flash (TARS) Tarsus Pharmaceuticals Posts Q4 Loss $0.20, vs. Loss of $0.60 a Year Ago - marketscreener.com
Tarsus Pharmaceuticals Reports Record $102.7 Million in Quarterly Net Product Sales of XDEMVY, a 152% Increase Year Over Year - Quiver Quantitative
Cherry Bekaert acquires Tarsus - LinkedIn
Earnings Preview: Tarsus Pharmaceuticals - Benzinga
TARS - Tarsus Pharmaceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
Tarsus earnings missed by $0.12, revenue topped estimates - Investing.com Nigeria
Tarsus Pharmaceuticals Q4 Loss Shrinks, Revenue Rise - marketscreener.com
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewswire
Sustained Growth Outlook for Tarsus Driven by XDEMVY’s Rapid Ramp and Expanding Lotilaner Pipeline - TipRanks
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 (NASDAQ:TARS) - Seeking Alpha
Earnings Flash (TARS) Tarsus Pharmaceuticals, Inc. Reports Q4 Revenue $151.7M, vs. FactSet Est of $144.6M - marketscreener.com
Earnings call transcript: Tarsus Pharmaceuticals beats Q3 2025 expectations - Investing.com
Informa Acquires Tarsus Group in $940 Million Mega Deal - Trade Show News Network
What's Next For Tarsus As Cash Reserves Fuel Pipeline And Global Reach? - RTTNews
Tarsus Pharmaceuticals at Guggenheim Conference: Strategic Growth and Innovation - Investing.com
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - simplywall.st
Analyst Estimates: Here's What Brokers Think Of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Second-Quarter Report - Yahoo Finance
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - Sahm
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates - Bitget
Tarsus (TARS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet? - simplywall.st
Relative Strength Alert For Tarsus Pharmaceuticals - Nasdaq
FOMO Trade: Will Tarsus Pharmaceuticals Inc benefit from rising consumer demand - 2025 Performance Recap & Low Risk Growth Stock Ideas - baoquankhu1.vn
BofA Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Announces Target Price $90 - 富途牛牛
Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $90 - 富途牛牛
Lyme Disease Is Spiking. This Biotech Nears A Treatment And A Buy Point. - Investor's Business Daily
Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts - Yahoo Finance
Tarsus Pharmaceuticals, Inc. to Host Live Webcast for Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth - Investing.com Nigeria
Insider Sell: Dianne Whitfield Sells 7,397 Shares of Tarsus Phar - GuruFocus
Barclays Initiates Coverage on Tarsus Pharmaceuticals (TARS) wit - GuruFocus
Earnings call transcript: Tarsus Pharmaceuticals Q2 2025 sees revenue beat - Investing.com
Raleigh accounting firm expands D.C. presence with acquisition - The Business Journals
Felix Tarsus George Obituary January 4, 2026 - Serenity Funeral Home | Kansas City, MO
Heritage on a plate: How EU support is helping to preserve Tarsus cuisine - EEAS
Cherry Bekaert boosts CFO advisory services - CFO Brew
Şişecam Commissioned New Energy Glass Lines in Tarsus - glassonweb.com
Foreign Language Equivalents
Foreign Language Equivalents of 'tarsus'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
yarsus, tasrus, trsus, taraus, rarsus, tarsud, tarssus, tarsys, tsrsus, tarsu, tarrsus, tarss, tarus, trasus, ttarsus, tardus, tarsua, taruss, arsus, taarsus, taesus, tarssu, tarsuss, tarsuus, tasus, tarsis, atrsus, tatsus
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z